Objective: Many children experience acute asthma exacerbations ,Many children
also require hospitalization despite treatment in an emergency department with current
standard therapy (corticosteroids ,and inhaled salbutamol). These hospitalizations
may be
avoided if effective adjunctive therapies can be developed to adequately treat severe
exacerbations.
Asthma exacerbations can be frequent and range in severity from relatively mild to
status asthmaticus. While the efficacy of intravenous MgSO4 hasbeen demonstrated, the
informations available on its inhaled role still low and conflicting, so the st
udy aim to
investigate the effect of thecombinationof MgSO4and salbutamol in the management of
acute asthma attack.
A randomized clinical trial was conducted on 76 patients, divided into two groups:
experimental (40) and control (36) patients. The trial received nebulised salbutamol with
magnesium sulphate and control nebulised salbutamol with saline serum 0.9% on three
sessions in 20 minutes. Signs of respiratory distress, wheezing, respiratory rate, pulse,
Sao2 and PEF were assessed.
Magnesium sulphate showed a significant effect in improving respiratory rate, Sao2
and PEF starting from the 20th minute( P <0.05), but did not observe the effect of MgSO4
in improving signs of respiratory distress, pulse and wheezing(P> 0,05), no side effects
attributed to magnesium sulphate were observed.Inhaled MgSO4, incombination with
salbutamol, appears to have benefits in the treatment of acute asthma attack.
Aim of study:The purpose of this study is to evaluate the effect of antiasthma drug (Budesonide) on oral health of asthmatic children during one year of treatment. Materials and Methods: Thirty children with asthma aged (5-10) years were selected fro
m the children who presented to children´s section at AL-Assad University Hospital in Lattakia with medium asthma severity and they needed to use antiasthma inhaled drug (Budesonide).This study have evaluated dental caries, gingival bleeding, dental plaque and saliva pH for each child before and after treatment with Budesonide in (3-6-9-12) months. Results: The results showed increasing in DMFT, dmft indices ,gingival bleeding index and dental plaque after follow- up for 12 months.
This study was done to determine whether use of nebulized salbutamol therapy for
treatment of an acute attack of asthma in children is associated with hypokalaemia and if
so what is its frequency, severity and what is accompanying clinical symptoms
103 child,
aged 3 years to 14 years with asthma attack, treated with three doses of nebulized
salbutamol 0.15mg/kg, every 20 min participated in the study. Blood for serum potassium
was obtained at the beginning and after three doses of nebulized salbutamol therapy.The
mean serum potassium level decreased from 3.94 mEq/L to 3.28 mEq/L (P < 0.05). A
decrease in serum potassium concentration was noted in 93 child (90.3%).). Mild
hypokalemia formed the highest proportion in 43child (41.7%) followed by moderate
hypokalemia in 28 child( 27.2%). Severe hypokalemia did not happen.This decrease was
accompanied with clinical symptoms (palpitations 23,muscle weakness 21,nausea 15,
headache 12,myalgia 11,vomiting 9).These symptoms were moreclosely to moderate
hypokalemia.
Asthma is the most common chronic disease in childhood, the
incidence progresses and constitutes a public health problem which needs
the research of factors that increase the incidence and severity of crisis, and
among these factors IgG4 deficiency. Therefore the objective of the study is
to know the effect of IgG4 deficiency on severity and evolution of asthma in
children.